Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Phase 2 Vaginal Proellex®-V, ZPV-200, study on track for full enrollment by end of June FDA requests review of all oral data prior to initiation of additional oral studies Repros...
-
THE WOODLANDS, Texas, May 22, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced it has modified the pivotal protocol following additional FDA input post the May 9th...
-
Submission starts 45 day PDUFA response clock for FDA comments Expecting to commence screening subjects for open label study THE WOODLANDS, Texas, May 16, 2012 (GLOBE NEWSWIRE) -- Repros...
-
THE WOODLANDS, Texas, May 15, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the first quarter ended March 31, 2012. Liquidity and...
-
Trial design discussed with FDA under Special Protocol Assessment (SPA) Safety exposure of 100 subjects for 1 year and 800 subjects for 6 months No requirement for positive...
-
Vaginal delivery of 12 mg Proellex exhibits the systemic drug exposure designed to optimize risk/benefit clinical profile Encouraging preliminary signs of efficacy in first cohort dosed with...
-
THE WOODLANDS, Texas, March 27, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the quarter and year ended December 31, 2011. Liquidity...
-
THE WOODLANDS, Texas, Feb. 27, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced that the FDA has granted a meeting with the Company to discuss the design of...
-
THE WOODLANDS, Texas, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced that they have closed a registered direct offering to sell an aggregate of...
-
THE WOODLANDS, Texas, Jan. 27, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced that it has entered into definitive agreements with certain institutional...